![Blair Jackson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Blair Jackson
Geschäftsführer bei
ALKERMES PLC
Vermögen: 10 Mio $ am 31.05.2026
Profil
Blair C. Jackson ist Mitglied des Vorstands von Alkermes Pharma Ireland Ltd. und Chief Operating Officer & Executive Vice President von Alkermes Plc. In seiner früheren Laufbahn war Herr Jackson Vice President-Business Development bei Alkermes, Inc. Herr Jackson erwarb einen Bachelor-Abschluss an der University of Calgary, einen MBA und einen Bachelor-Abschluss an der University of Alberta und einen Master-Abschluss am Massachusetts Institute of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.03.2026 | 241’308 ( 0.14% ) | 10 Mio $ | 31.05.2026 |
Aktive Positionen von Blair Jackson
| Unternehmen | Position | Beginn |
|---|---|---|
| ALKERMES PLC | Geschäftsführer | 11.01.2021 |
Alkermes Pharma Ireland Ltd.
 Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures oral dosage products | Direktor/Vorstandsmitglied | - |
Synchronicity Pharma, Inc.
 Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops and commercializes novel therapeutics | Direktor/Vorstandsmitglied | 01.10.2018 |
Rodin Therapeutics, Inc.
 Rodin Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disorders | Vorsitzender | - |
Ehemalige bekannte Positionen von Blair Jackson
| Unternehmen | Position | Ende |
|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Corporate Officer/Principal | 01.01.2021 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Direktor/Vorstandsmitglied | 01.01.2015 |
Ausbildung von Blair Jackson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
57
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Calgary
 University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops and commercializes novel therapeutics | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Alkermes Pharma Ireland Ltd.
Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures oral dosage products | Health Technology |
Rodin Therapeutics, Inc.
Rodin Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disorders | Health Technology |
